Found 331 matching trials
Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive or Exposed to BCG Therapy PHASE2 interventional study of intravesical chemotherapy and sistemic immunotherap...
Show More Learn More & Join Trial
LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic Patients NA This is a Single arm, Simon's two stage pilot study in which patients with ...
Show More Location
University of Illinois Cancer Center
Learn More & Join Trial
Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma PHASE1 This phase I/II trial studies the side effects and best dose of hydroxychlo...
Show More Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Learn More & Join Trial
TIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Directed TKI and Platinum-doublet Chemotherapy PHASE3 The purpose of this study is to compare the anti-tumor efficacy of oral sin...
Show More Location
Comprehensive Blood and Cancer Center
Learn More & Join Trial
Gemcitabine and Docetaxel Therapy in High-risk BCG-naive Patients With Non-muscle Invasive Bladder Cancer NA Bacillus Calmette-Guerin (BCG) is the standard of care for high-risk patien...
Show More Location
University Hospital Centre Zagreb
Learn More & Join Trial
Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas PHASE1 The purpose of this study is to test the combination of the chemotherapy dr...
Show More Location
University of Iowa Hospitals and Clinics
Learn More & Join Trial
Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III) PHASE2 This study is for patients with locally advanced pancreatic cancer (cancer ...
Show More Location
Columbia University Medical Center
Learn More & Join Trial
Study of Gemzar®, Taxotere®, and Xeloda® (GTX) in Patients With Metastatic Pancreatic Cancer (Stage IVB) PHASE2 This study is designed to determine whether an investigational drug combina...
Show More Location
Columbia University Medical Center
Learn More & Join Trial
Neoadjuvant Aliya™ PEF Soft Tissue Ablation With Systemic Therapy in Early-Stage Resectable NSCLC PHASE4 A prospective, single-arm, non-randomized, multi-center, open-label study f...
Show More Location
Mayo Clinic Rochester
Learn More & Join Trial
Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
University of California San Diego
Learn More & Join Trial